Zee, S.T.J.; Kwok, L.F.; Kee, C.K.M.; Fung, L.H.; Luk, L.W.P.; Chan, C.T.L.; Leung, A.C.P.; Yu, B.P.W.; Hung, J.R.L.; SzeTo, K.Y.; Chan, Q.W.L.; Tang, B.S.F.; Lin, A.W.C.; Ma, E.S.K.; Lee, K.H.; Lau, C.C.; Hung Yung, R.W. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong. Vaccines2022, 10, 1322.
Zee, S.T.J.; Kwok, L.F.; Kee, C.K.M.; Fung, L.H.; Luk, L.W.P.; Chan, C.T.L.; Leung, A.C.P.; Yu, B.P.W.; Hung, J.R.L.; SzeTo, K.Y.; Chan, Q.W.L.; Tang, B.S.F.; Lin, A.W.C.; Ma, E.S.K.; Lee, K.H.; Lau, C.C.; Hung Yung, R.W. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong. Vaccines 2022, 10, 1322.
Zee, S.T.J.; Kwok, L.F.; Kee, C.K.M.; Fung, L.H.; Luk, L.W.P.; Chan, C.T.L.; Leung, A.C.P.; Yu, B.P.W.; Hung, J.R.L.; SzeTo, K.Y.; Chan, Q.W.L.; Tang, B.S.F.; Lin, A.W.C.; Ma, E.S.K.; Lee, K.H.; Lau, C.C.; Hung Yung, R.W. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong. Vaccines2022, 10, 1322.
Zee, S.T.J.; Kwok, L.F.; Kee, C.K.M.; Fung, L.H.; Luk, L.W.P.; Chan, C.T.L.; Leung, A.C.P.; Yu, B.P.W.; Hung, J.R.L.; SzeTo, K.Y.; Chan, Q.W.L.; Tang, B.S.F.; Lin, A.W.C.; Ma, E.S.K.; Lee, K.H.; Lau, C.C.; Hung Yung, R.W. Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong. Vaccines 2022, 10, 1322.
Abstract
Immune escape is observed with SARS-CoV-2 Omicron (Pango lineage B.1.1.529), the predominant circulating strain worldwide. Booster dose was shown to restore immunity against Omicron infection, however, real world data comparing mRNA (BNT162b2; Comirnaty) and inactivated vaccine (CoronaVac; Sinovac) homologous and heterologous boosting is lacking. A retrospective study was performed to compare the rate and outcome of COVID-19 in healthcare workers (HCWs) with various vaccination regime during a territory-wide Omicron outbreak in Hong Kong. During the study period 1 Feb – 31 Mar 2022, 3167 HCWs were recruited, 871 HCWs reported 746 and 183 episodes of significant household and non-household close contact. 737 HCWs acquired COVID-19 which were all clinically mild. Time dependent Cox regression showed that, comparing with 2-dose vaccination, 3-dose vaccination reduced infection risk by 31.7% and 89.3% in household contact and non-household close contact respectively. Using 2-dose BNT162b2 as reference, 2-dose CoronaVac recipient had significantly higher risk of being infected (HR 1.69 P<0.0001). Three-dose BNT162b2 (HR 0.4778 P<0.0001) and 2-dose CoronaVac + BNT162b2 booster (HR 0.4862 P=0.0157) were associated with lower risk of infection. Three-dose CoronaVac and 2-dose BNT162b2 + CoronaVac booster were not significantly different from 2-dose BNT162b2. The mean time to achieve negative RT-PCR or E gene cycle threshold 31 or above was not affected by age, number of vaccine dose taken, vaccine type and timing of the last dose. In summary, we have demonstrated lower risk of breakthrough SARS-CoV-2 infection in HCWs given BNT162b2 as booster after 2 doses of BNT162b2 or CoronaVac.
Biology and Life Sciences, Immunology and Microbiology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
